Skip to content

12 week Yoga effect on metabolite, transcriptome and microbiota profile of PCOS women

Elucidating the impact of yoga-based Lifestyle-Intervention on Metabolites, Transcriptome Dynamics, and Microbiota composition for Personalized Interventions in Polycystic Ovary Syndrome A descriptive study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082802
Enrollment
40
Registered
2025-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

Intervention1: Yoga: 12-week Yoga-based Lifestyle Modification Program (YLMP) Control Intervention1: Controls: Not applicable

Sponsors

Dr Rima Dada
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: confirmed PCOS diagnosis based on the Rotterdam consensus, age between 15 and 40 years, Indian ethnicity, and willingness to provide consent.

Exclusion criteria

Exclusion criteria: Participants unable to attend follow-ups and provide consent, along with those having inflammatory arthritis, lower limb pathologies hindering yoga participation, known causes of infertility and androgen excess, severe endometriosis, severe male factor infertility, and documented severe tubal bilateral pathology.

Design outcomes

Primary

MeasureTime frame
To assess hormonal profileTimepoint: 1 years

Secondary

MeasureTime frame
1. To assess metabolomic profiles in pre- and post-Yoga interventions in PCOS, compared to healthy controls (HC). 2.To investigate changes in the transcriptome profile using NGS and validate active transcripts through RT-PCR at pre- and post-yoga intervention in PCOS, compared to HC. 3.To evaluate gut microbiota dysbiosis profiling using NGS pre- and post-yoga intervention in PCOS, compared to HC. 4.To validate identified transcriptomics using yoga-primed serum in PCOS-specific cell lines (GCP-01 and KGN cell line).Timepoint: 1,2,3,4 objectives - 1-3 years

Countries

India

Contacts

Public ContactDr Rima Dada

AIIMS, New delhi

rimadadaaiims20@gmail.com9811783318

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026